Ganjoo Discusses Treatment Plans, Patient Conversations, and the Role of Nab-Sirolimus in Malignant PEComa

Dr Ganjoo discusses unmet needs for patients with malignant PEComa, treatment plan considerations, and the use of nab-sirolimus in this disease.

Related Keywords

California ,United States ,Stanford ,Courtney Flaherty ,Kristenn Ganjoo ,Aadi Biosciences ,Facebook ,Linkedin ,Twitter ,Stanford Health Care ,Live On Air ,Stanford Medicine ,Onclive On Air ,Apple Podcasts ,Google Podcasts ,Amazon Music ,